Navigation Links
PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP

Woburn, Mass. (PRWEB) July 11, 2013

PathoGenetix™, Inc., a commercial-stage developer of an automated system for rapid bacterial identification, will participate in the 2013 International Association for Food Protection (IAFP) Annual Meeting taking place in Charlotte, North Carolina, from July 28-31. A sustaining member of IAFP, PathoGenetix plans to demonstrate its new RESOLUTION™ Microbial Genotyping System for the first time at the meeting, and to present two new research studies detailing the differentiation and typing of Salmonella strains, from both pure culture and complex “presumptive positive” food samples, in five hours.

The IAFP Annual Meeting provides information on current and emerging food safety issues, and is the leading food safety conference worldwide. The conference addresses the latest science and solutions on new and recurring issues in food safety, and includes technical papers, posters and symposia on a variety of topics related to food safety.

The RESOLUTION Microbial Genotyping System is based on PathoGenetix’s proprietary Genome Sequence Scanning™ (GSS™) technology, a breakthrough in microbial identification with significant advantages for food safety testing and outbreak investigations. GSS works directly from complex mixtures such as enriched food samples or from pure culture isolates, and automates the identification process from sample preparation to data analysis. As a result, the RESOLUTION System can provide actionable information in five hours, days faster than current identification methods, and offer food producers a valuable new tool for identifying house strains or conducting traceback analysis.

The RESOLUTION System also provides public health labs and government agencies the potential for faster source tracking in foodborne illnesses outbreak investigation. The typing resolution of GSS is comparable to PFGE, the current standard for pathogen identification in outbreak investigations. Yet because the technology works in mixed culture, it can provide critical strain information in a culture independent diagnostics environment. The System’s automated platform and simplified protocol require minimal training, and strain type results can be quickly and easily shared across laboratory networks.

PathoGenetix will exhibit the RESOLUTION System at IAFP beginning on Sunday, July 28, at 7:30 PM and continuing through Tuesday, July 30, at 6:00 PM. For more information or to schedule a demonstration of the technology, email info(at)pathogenetix(dot)com.

PathoGenetix research detailing the serotyping and strain typing capabilities of Genome Sequence Scanning in a variety of matrices will be presented at IAFP in two poster sessions on Tuesday, July 30, and Wednesday, July 31. For a full schedule of educational sessions and events at the 2013 IAFP Annual Meeting, visit

About PathoGenetix, Inc.

PathoGenetix™, Inc. is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The core Genome Sequence Scanning™ (GSS™) technology analyzes DNA directly from an enriched biological sample—without the need for a cultured isolate—and provides results in just five hours, days faster than current methods. GSS has broad applicability in food safety, industrial microbiology, and clinical diagnostics and research. The GSS technology will be available in the RESOLUTION™ Microbial Genotyping System in 2014 for use in food safety testing and foodborne illness outbreak investigations. Learn more at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System
2. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
3. PathoGenetix and FDA to Evaluate Bacterial Identification System for Use in FDA Public Health and Food Safety Efforts
4. PathoGenetix Adds Director of Manufacturing and Begins Production of New Rapid Bacterial Strain Typing System
5. PathoGenetix Hires Food Safety Testing Expert John W. Czajka as Vice President of Business Development
6. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
7. Leica Microsystems Debuts First 3D Surgical Microscopes with TrueVision® Technology Inside, at AANS Annual Meeting in New Orleans
8. Tianli-Xiduhei(TM) Black Pork Meat Makes Official Debut in Beijing Food Stores
9. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
10. New Genotyping System Identifies Pathogenic E. coli Outbreak Strains
11. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):